Symptomatic Ferric Carboxymaltose‐Induced Hypophosphataemia: A Case Series of 11 Patients
Marina Weerheim, Heva Korevaar, Maurice Bizino, Gijs Fortrie, Loes Vrolijk, Ted Koster, Faiz Karim · 2026
Read Symptomatic Ferric Carboxymaltose‐Induced Hypophosphataemia: A Case Series of 11 Patients by Marina Weerheim, Heva Korevaar, Maurice Bizino, Gijs Fortrie, Loes Vrolijk, Ted Koster, Faiz Karim (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13500041.txt.
Description
Marina Weerheim and co-authors present a 2026 case series, written as a letter, on a side effect of a widely used intravenous iron drug. The drug delivers large iron doses in one sitting and suits patients who cannot take pills. Trials and expert guidance agree it raises the risk of low blood phosphate more than rival products.
Even so, severe cases with real symptoms still occur in daily practice and often go unrecognized, since phosphate is not checked as a routine. The authors describe eleven such patients. Their shared lesson is that teams should watch for the drop, test phosphate after treatment, and act early when symptoms appear. The series aims to raise awareness among clinicians who prescribe the drug.
Catalog record
| CREATOR | Marina Weerheim, Heva Korevaar, Maurice Bizino, Gijs Fortrie, Loes Vrolijk, Ted Koster, Faiz Karim |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 18 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |